MCM3AP and cancer: The results showed that MCM3AP-AS1 expression was upregulated in a variety of cancers, including cholangiocarcinoma (CHOL), esophageal carcinoma (ESCA), lymphoid neoplasm diffuse large B-cell lymphoma (DLBC), kidney renal clear cell carcinoma (KIRC), head and neck squamous cell carcinoma (HNSC), brain lower grade glioma (LGG), acute myeloid leukemia (LAML), pheochromocytoma and paraganglioma (PCPG), sarcoma (SARC), and thymoma (THYM) (Figure 7).